Takeda Pharmaceutical Company Limited (4502)

Basic

  • Market Cap

    ¥6,499.98B

  • EV

    ¥11.44T

  • Shares Out

    1,568.91M

  • Revenue

    ¥4,154.41B

  • Employees

    49,095

Margins

  • Gross

    68.24%

  • EBITDA

    28.81%

  • Operating

    13.9%

  • Pre-Tax

    4.67%

  • Net

    4.61%

  • FCF

    19.5%

Returns (5Yr Avg)

  • ROA

    2.14%

  • ROE

    4.35%

  • ROCE

    4.1%

  • ROIC

    2.49%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    ¥4,687.89

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    ¥2,667.57

  • Earnings (Dil)

    ¥121.56

  • FCF

    ¥513.94

  • Book Value

    ¥4,506.6

Growth (CAGR)

  • Rev 3Yr

    8.84%

  • Rev 5Yr

    18.61%

  • Rev 10Yr

    10.02%

  • Dil EPS 3Yr

    50.45%

  • Dil EPS 5Yr

    -7.42%

  • Dil EPS 10Yr

    2.34%

  • Rev Fwd 2Yr

    -1.29%

  • EBITDA Fwd 2Yr

    -2.21%

  • EPS Fwd 2Yr

    -14.48%

  • EPS LT Growth Est

    4.08%

Dividends

  • Yield

    —

  • Payout

    149.54%

  • DPS

    ¥184

  • DPS Growth 3Yr

    0.74%

  • DPS Growth 5Yr

    0.44%

  • DPS Growth 10Yr

    0.22%

  • DPS Growth Fwd 2Yr

    2.57%

Select a metric from the list below to chart it

Mar '14
Mar '16
Mar '18
Mar '20
Mar '22
LTM
Metric
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
LTM

Total Revenues

2,097,224.0

3,291,188.0

3,197,812.0

3,569,006.0

4,027,478.0

4,154,414.0

Total Revenues % Chg.

18.5%

56.9%

-2.8%

11.6%

12.8%

10.8%

Cost of Goods Sold, Total

651,694.0

1,120,146.0

1,013,655.0

1,127,308.0

1,253,163.0

1,319,532.0

Gross Profit

1,445,530.0

2,171,042.0

2,184,157.0

2,441,698.0

2,774,315.0

2,834,882.0

Selling General & Admin Expenses, Total

692,728.0

964,268.0

875,514.0

886,327.0

997,234.0

1,018,085.0

R&D Expenses

368,257.0

492,088.0

455,765.0

526,087.0

633,325.0

682,260.0

Depreciation & Amortization

—

—

—

—

—

—

Amortization of Goodwill and Intangible Assets

169,919.0

407,343.0

405,229.0

418,789.0

485,102.0

501,324.0

Other Operating Expenses

-1,899.0

10,663.0

23,602.0

10,433.0

38,987.0

55,554.0

Other Operating Expenses, Total

1,229,005.0

1,874,362.0

1,760,110.0

1,841,636.0

2,154,648.0

2,257,223.0

Operating Income

216,525.0

296,680.0

424,047.0

600,062.0

619,667.0

577,659.0

Interest Expense, Total

-48,158.0

-149,010.0

-130,806.0

-122,432.0

-116,973.0

-158,050.0

Interest And Investment Income

9,233.0

12,646.0

2,153.0

4,763.0

5,781.0

—

Net Interest Expenses

-38,925.0

-136,364.0

-128,653.0

-117,669.0

-111,192.0

-158,050.0

Income (Loss) On Equity Invest.

-43,627.0

-23,987.0

76.0

-15,367.0

-8,630.0

-5,657.0

Currency Exchange Gains (Loss)

7,007.0

10,979.0

-15,575.0

-3,903.0

-9,729.0

-9,729.0

Other Non Operating Income (Expenses)

-14,683.0

-10,631.0

1,118.0

-25,076.0

3,975.0

2,616.0

EBT, Excl. Unusual Items

126,297.0

136,677.0

281,013.0

438,047.0

494,091.0

406,839.0

Restructuring Charges

-82,962.0

-181,831.0

-115,875.0

-83,836.0

-59,234.0

-73,150.0

Merger & Related Restructuring Charges

-40,619.0

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

8,482.0

22,416.0

22,416.0

Gain (Loss) On Sale Of Assets

131,193.0

19,871.0

235,117.0

8,164.0

8,901.0

8,901.0

Asset Writedown

-9,319.0

-60,974.0

-17,521.0

-54,421.0

-62,484.0

-142,284.0

Insurance Settlements

799.0

8,279.0

—

—

—

—

Legal Settlements

—

—

-17,401.0

-20,319.0

-16,455.0

-16,455.0

Other Unusual Items

2,223.0

17,224.0

902.0

6,454.0

-12,145.0

-12,145.0

EBT, Incl. Unusual Items

127,612.0

-60,754.0

366,235.0

302,571.0

375,090.0

194,122.0

Income Tax Expense

-7,468.0

-105,044.0

-9,936.0

72,405.0

58,052.0

2,401.0

Earnings From Continuing Operations

135,080.0

44,290.0

376,171.0

230,166.0

317,038.0

191,721.0

Minority Interest

112.0

-49.0

-166.0

-107.0

-21.0

-95.0

Net Income

135,192.0

44,241.0

376,005.0

230,059.0

317,017.0

191,626.0

Net Income to Common Incl Extra Items

135,192.0

44,241.0

376,005.0

230,059.0

317,017.0

191,626.0

Net Income to Common Excl. Extra Items

135,192.0

44,241.0

376,005.0

230,059.0

317,017.0

191,626.0

Total Shares Outstanding

1,554.8

1,557.8

1,563.4

1,550.4

1,554.5

1,568.9

Weighted Avg. Shares Outstanding

961.5

1,557.2

1,562.0

1,563.5

1,551.8

1,557.4

Weighted Avg. Shares Outstanding Dil

966.9

1,566.2

1,573.5

1,577.2

1,569.9

1,576.4

EPS

140.6

28.4

240.7

147.1

204.3

123.0

EPS Diluted

139.8

28.3

239.0

145.9

201.9

121.6

EBITDA

464,216.0

880,329.0

983,718.0

1,112,892.0

1,210,650.0

1,196,729.0